Skip to content
10-Q

Quarterly Report

Solid Biosciences Inc. SLDB

0000950170-25-072560

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 77.52M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $28.78M
Current Liabilities Q1 2025 · Dec 31, 2024 $30.26M
Total Liabilities Q1 2025 · Mar 31, 2025 $49.44M
Total Liabilities Q1 2025 · Dec 31, 2024 $51.42M
Current Assets Q1 2025 · Mar 31, 2025 $313.41M
Current Assets Q1 2025 · Dec 31, 2024 $157.3M
Total Assets Q1 2025 · Mar 31, 2025 $343.9M
Total Assets Q1 2025 · Dec 31, 2024 $188.66M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $80.24M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $117.57M
Shares Diluted Q1 2025 · Mar 31, 2024 38.16M sh
Capex Q1 2025 · Mar 31, 2024 $149K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$25.19M
Stockholders Equity Q1 2025 · Mar 31, 2024 $210.72M
Stockholders Equity Q1 2025 · Dec 31, 2023 $126.48M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.64
Eps Basic Q1 2025 · Mar 31, 2024 −$0.64
Sga Expense Q1 2025 · Mar 31, 2024 $7.99M
Rd Expense Q1 2025 · Mar 31, 2024 $18.87M
Operating Income Q1 2025 · Mar 31, 2024 −$26.86M